Hyperacute Stroke Infarction Management

Initial Assessment and Stabilization

The American Heart Association recommends immediate contact with Emergency Medical Services (EMS) for suspected stroke patients 1
EMS personnel should use standardized acute stroke screening tools during on-scene assessment 1
Upon hospital arrival, rapid assessment of airway, breathing, and circulation (ABCs) should be performed immediately 2, 3
Cardiac monitoring should be initiated during the initial evaluation to detect atrial fibrillation and potentially life-threatening arrhythmias 2, 3
All patients with suspected stroke should undergo urgent brain imaging (CT or MRI) within 24 hours, but ideally as soon as possible 4

Neuroimaging and Diagnosis

Brain CT or MRI is essential to differentiate between ischemic and hemorrhagic stroke, according to the American College of Cardiology 5, 4
Vascular imaging (CT angiography, MR angiography) should be performed to identify large vessel occlusions that may be amenable to endovascular therapy, as recommended by the American College of Cardiology 5
For patients with carotid territory symptoms who might be candidates for carotid revascularization, urgent carotid duplex ultrasound should be performed 4

Reperfusion Therapies

Intravenous tissue plasminogen activator (tPA/alteplase) is highly effective for selected patients when administered within 3 hours of symptom onset, with a strength of evidence level of I (high) 4
Blood pressure must be <185/110 mmHg before administering tPA, as recommended by the American Heart Association 6
Patients receiving tPA require close monitoring for 24 hours with strict blood pressure management, according to the American Heart Association 6
Endovascular treatment (mechanical thrombectomy) should be considered for patients with large vessel occlusion, with a strength of evidence level of I (high), as recommended by the American College of Cardiology 5
A combined approach using stent-retrievers and aspiration is most effective for achieving complete reperfusion, according to the American College of Cardiology 5
Time to reperfusion is critical - every 30-minute delay decreases the chance of good functional outcome by 8-14%, with a strength of evidence level of II (moderate) 5

Blood Pressure Management

For patients not receiving thrombolytic therapy, antihypertensive agents should generally be withheld unless systolic BP >220 mmHg or diastolic BP >120 mmHg, as recommended by the American Heart Association 2, 3, 7
When treatment is indicated, blood pressure should be lowered cautiously by 15-25% within the first day, according to the American Heart Association 7
Preferred agents include labetalol or nicardipine which can be easily titrated, as recommended by the American Heart Association 6
For patients receiving thrombolytic therapy, blood pressure must be maintained below 185/110 mmHg before treatment and below 180/105 mmHg for the first 24 hours after treatment, according to the American Heart Association 6

Management of Other Physiological Parameters

Promptly measure serum glucose and correct hypoglycemia immediately, as recommended by the American Heart Association 2, 3
Hyperglycemia is associated with poor outcomes and should be managed, though optimal targets remain uncertain, with a strength of evidence level of III (low) 2, 3
Treat sources of fever and use antipyretics to control elevated temperatures, according to the American Heart Association 2, 3
Provide supplemental oxygen to hypoxic patients, as recommended by the American Heart Association 2, 3
Non-hypoxic patients do not require supplemental oxygen, according to the American Heart Association 2, 3

Post-Acute Care

Aspirin (160-300 mg/day) should be started within 48 hours of onset for ischemic stroke patients not receiving thrombolysis, as recommended by the American Heart Association 4
Patients should be monitored in a stroke unit or intensive care unit with specialized neuroscience expertise, with a strength of evidence level of I (high) 8
Perform validated neurological scale assessments at baseline and repeat at least hourly for the first 24 hours, according to the American Heart Association 8
Implement intermittent pneumatic compression for prevention of venous thromboembolism, as recommended by the American Heart Association 8
Conduct formal screening for dysphagia before initiating oral intake, according to the American Heart Association 8

Common Pitfalls and Considerations

Delaying imaging or treatment decisions while waiting for diagnostic test results, with a strength of evidence level of III (low) 8
Aggressively lowering blood pressure in acute ischemic stroke, which may reduce cerebral perfusion and expand infarction, with a strength of evidence level of II (moderate) 7
Using sublingual nifedipine or other agents that cause precipitous blood pressure reduction, according to the American Heart Association 6
Failing to recognize early neurological deterioration, which is common in the first few hours, with a strength of evidence level of III (low) 8
Overlooking the importance of time - "time is brain" - delays in treatment significantly impact outcomes, with a strength of evidence level of I (high) 5

Hyperacute Stroke Management

Definition and Temporal Context

The American Heart Association defines hyperacute stroke as the first 24 hours after symptom onset for ischemic and hemorrhagic stroke, and up to 48 hours for transient ischemic attack (TIA), during which time-sensitive interventions can improve outcomes 9, 10
The hyperacute period encompasses all prehospital care, emergency department assessment, initial stabilization, diagnostic imaging, and acute reperfusion therapies, emphasizing the importance of rapid action 9, 10

Clinical Significance and Time Sensitivity

Every minute of untreated ischemic stroke results in the death of 1.9 million brain cells, along with 13.8 billion synapses and 12 km of axonal fibers, highlighting the urgent need for intervention 9, 10, 11
Every hour without treatment is equivalent to the brain aging 3.6 years, underscoring the critical nature of timely care 9, 10
The Canadian Stroke Best Practice Recommendations emphasize that hyperacute care is "time sensitive by nature, minutes for disabling stroke and hours for TIA" 9, 10

Assessment, Diagnosis, and Treatment

Determination of "last known well time" is crucial for treatment eligibility, as it guides the timing of interventions such as intravenous thrombolysis and endovascular therapy 12
Emergency neurosurgical procedures may be necessary for complications of hemorrhagic stroke, and blood pressure management is critical, with different targets for ischemic and hemorrhagic stroke 9, 10

System-Level Implications and Coordination

Prehospital notification by EMS with detailed patient information is essential to activate stroke teams before arrival, ensuring timely care 9
Interdisciplinary teams, including paramedics, ED physicians, stroke neurologists, and neurointerventionalists, must work in seamless coordination to provide optimal hyperacute stroke care 9, 10

Blood Pressure Management in Acute Stroke with Severe Vertebral Artery Stenosis

Hemodynamic Vulnerability in Vertebral Stenosis

Patients with severe vertebral artery stenosis depend on elevated systemic blood pressure to maintain cerebral perfusion; a drop in blood pressure markedly increases the risk of hypoperfusion‑related stroke. 13
Impaired cerebrovascular reactivity associated with severe vertebral stenosis is linked to a higher incidence of ipsilateral ischemic events. 14
The benefit or harm of antihypertensive therapy in symptomatic patients with severe vertebral artery stenosis remains uncertain because lowering blood pressure may reduce cerebral perfusion through the narrowed vessel. 15

Acute Stroke Blood Pressure Guidelines (AHA/ASA)

The American Heart Association/American Stroke Association (AHA/ASA) guidelines warn that aggressive blood‑pressure lowering in the acute stroke setting can cause neurological worsening. 16
Each 10 % reduction in blood pressure during acute stroke is associated with an odds ratio of 1.89 for an unfavorable outcome. 17
Reductions in systolic or diastolic pressure > 20 mm Hg are correlated with early neurological deterioration, higher rates of poor outcome or death, and larger infarct volumes. 17
Initiating antihypertensive therapy in patients with a systolic blood pressure > 180 mm Hg in the acute phase is linked to a marked increase in early deterioration, poor neurological outcome, or death. 18

Standard Acute Stroke BP Management Recommendations

For patients not receiving thrombolytic therapy, antihypertensive agents should generally be withheld unless systolic > 220 mm Hg or diastolic > 120 mm Hg. 16
Using a PRN threshold of systolic > 180 mm Hg for antihypertensive treatment falls below the guideline‑recommended treatment threshold and may be inappropriate. 18
When blood‑pressure reduction is indicated, the decrease should be limited to 15–25 % of the baseline value within the first 24 hours to avoid compromising cerebral perfusion. 16

Adjusted BP Targets for Patients with Severe Vertebral Stenosis

In patients with severe vertebrobasilar stenosis, standard acute‑stroke BP targets may be unsafe; permissive hypertension (maintaining systolic pressure in the 140–160 mm Hg range or higher) should be considered to preserve cerebral flow. 13
Treating blood pressure to < 180 mm Hg in the presence of critical vertebral stenosis can lower perfusion pressure below the threshold needed to sustain flow through the narrowed vessel. 16

Clinical Pitfalls and Imaging Considerations

Failure to recognize that severe vertebral stenosis creates a hemodynamically vulnerable state can lead to inappropriate blood‑pressure lowering and subsequent hypoperfusion stroke. 13
Urgent neurovascular imaging (CTA or MRA) should be obtained before making aggressive blood‑pressure management decisions in any patient presenting with posterior‑circulation symptoms. 13
The complexity of balancing acute infection management with stroke prevention in patients with critical vertebral stenosis means that reasonable clinicians may disagree on the optimal blood‑pressure strategy. 15